Anna Mae Wu
Affiliations: | Molecular and Medical Pharmacology | University of California, Los Angeles, Los Angeles, CA |
Area:
engineered antibodies for cancer targetingWebsite:
https://www.crunchbase.com/person/anna-m-wu#section-overviewGoogle:
"Anna Mae Wu"Bio:
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Terry Platt | grad student | 1979 | Yale | |
| (Termination of transcription at the 3? end of the tryptophan operon in E. coli.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zettlitz KA, Salazar FB, Yamada RE, et al. (2022) 89Zr-ImmunoPET shows therapeutic efficacy of anti-CD20 interferon-α fusion protein in a murine B-cell lymphoma model. Molecular Cancer Therapeutics |
| Gamache RF, Zettlitz KA, Tsai WK, et al. (2020) Tri-functional platform for construction of modular antibody fragments for F-PET or NIRF molecular imaging. Chemical Science. 11: 1832-1838 |
| Dai H, Ma Z, Wang F, et al. (2020) Advancing nanomedicine with cross-link functionalized nanoparticles for rapid excretion. Angewandte Chemie (International Ed. in English) |
| Tsai WK, Zettlitz KA, Dahlbom M, et al. (2020) Evaluation of [I]I- and [Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer. Molecular Imaging and Biology |
| Bäck TA, Jennbacken K, Hagberg Thulin M, et al. (2020) Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors. Ejnmmi Research. 10: 10 |
| Akhavan D, Yazaki P, Yamauchi D, et al. (2020) Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies. Cancer Biotherapy & Radiopharmaceuticals |
| Gamache RF, Zettlitz KA, Tsai WK, et al. (2020) Tri-functional platform for construction of modular antibody fragments for in vivo18F-PET or NIRF molecular imaging Chemical Science. 11: 1832-1838 |
| Pandit-Taskar N, Postow M, Hellmann M, et al. (2019) First-in-human imaging with Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Kasten BB, Udayakumar N, Leavenworth JW, et al. (2019) Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology. Theranostics. 9: 5085-5104 |
| Zettlitz KA, Tsai WK, Knowles SM, et al. (2019) [Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging |